Prognostic value of response after upfront therapy for acute GVHD

One challenge in designing clinical trials for treatment of acute GVHD (aGVHD) is the lack of an established standardized end point to measure the success of therapies. To facilitate assessment of end points in clinical trials for treatment of aGVHD in the current allo-SCT era, a national workshop w...

Full description

Saved in:
Bibliographic Details
Main Authors: Saliba, RM, Couriel, DR, Giralt, S, Rondon, G, Okoroji, G-J, Rashid, A, Champlin, RE, Alousi, AM
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4114039/
https://ncbi.nlm.nih.gov/pubmed/21383686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2011.41
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items